Literature DB >> 2293495

Applications of the International Classification of Diseases.

P H Wood1.   

Abstract

A brief outline is given of how various types of adaptation of the ICD for use in different situations have arisen. The application includes condensed lists, national adaptations, studies of morbidity, specialty adaptations (including for primary care), and augmentation by supplementary material. The major purposes of different applications are reviewed and an indication is given of factors influencing selection of the condition of primary interest in such situations. The article concludes by suggesting guidance for the development of applications and adaptations of the ICD.

Entities:  

Mesh:

Year:  1990        PMID: 2293495

Source DB:  PubMed          Journal:  World Health Stat Q        ISSN: 0379-8070


  5 in total

1.  Are the Domains Considered by ICF Comprehensive Enough to Conceptualize Participation in the Patient with Hand Injuries?

Authors:  Maryam Farzad; Fereydoun Layeghi; Seyyed Ali Hosseini; Khanke Hamidreza; Ali Asgari
Journal:  J Hand Microsurg       Date:  2017-11-29

2.  The Assessment of the Readiness of Molecular Biomarker-Based Mobile Health Technologies for Healthcare Applications.

Authors:  Chu Qin; Lin Tao; Yik Hui Phang; Cheng Zhang; Shang Ying Chen; Peng Zhang; Ying Tan; Yu Yang Jiang; Yu Zong Chen
Journal:  Sci Rep       Date:  2015-12-08       Impact factor: 4.379

Review 3.  ICD-11: an international classification of diseases for the twenty-first century.

Authors:  James E Harrison; Stefanie Weber; Robert Jakob; Christopher G Chute
Journal:  BMC Med Inform Decis Mak       Date:  2021-11-09       Impact factor: 2.796

4.  Therapeutic target database update 2014: a resource for targeted therapeutics.

Authors:  Chu Qin; Cheng Zhang; Feng Zhu; Feng Xu; Shang Ying Chen; Peng Zhang; Ying Hong Li; Sheng Yong Yang; Yu Quan Wei; Lin Tao; Yu Zong Chen
Journal:  Nucleic Acids Res       Date:  2013-11-21       Impact factor: 16.971

5.  Potential Compounds for Oral Cancer Treatment: Resveratrol, Nimbolide, Lovastatin, Bortezomib, Vorinostat, Berberine, Pterostilbene, Deguelin, Andrographolide, and Colchicine.

Authors:  Saurabh Bundela; Anjana Sharma; Prakash S Bisen
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.